{"id":"NCT01468181","sponsor":"Eli Lilly and Company","briefTitle":"A Study of LY2189265 in Japanese Participants With Type 2 Diabetes Mellitus","officialTitle":"A 52-Week, Open-Label, Long-Term Safety Study of LY2189265 in Combination With Monotherapy of Oral Antihyperglycemic Medications in Patients With Type 2 Diabetes Mellitus","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2011-11","primaryCompletion":"2013-12","completion":"2013-12","firstPosted":"2011-11-09","resultsPosted":"2014-12-16","lastUpdate":"2015-01-29"},"enrollment":394,"design":{"allocation":"NON_RANDOMIZED","model":"PARALLEL","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Type 2 Diabetes Mellitus"],"interventions":[{"type":"DRUG","name":"LY2189265","otherNames":["Dulaglutide"]},{"type":"DRUG","name":"Sulfonylureas (SU)","otherNames":[]},{"type":"DRUG","name":"Biguanides (BG)","otherNames":[]},{"type":"DRUG","name":"alpha-glucosidase inhibitor (a-GI)","otherNames":[]},{"type":"DRUG","name":"Thiazolidinedione (TZD)","otherNames":[]},{"type":"DRUG","name":"Glinides","otherNames":[]}],"arms":[{"label":"LY2189265 + Sulfonylureas (SU)","type":"EXPERIMENTAL"},{"label":"LY2189265 + Biguanides (BG)","type":"EXPERIMENTAL"},{"label":"LY2189265 + alpha-glucosidase inhibitor (a-GI)","type":"EXPERIMENTAL"},{"label":"LY2189265 + Thiazolidinedione (TZD)","type":"EXPERIMENTAL"},{"label":"LY2189265 + Glinides","type":"EXPERIMENTAL"}],"summary":"This was a 52-week, multicenter, non-randomized, open-label, Phase 3 long-term safety study in participants with type 2 diabetes mellitus who have inadequate glycemic control with monotherapy of oral antihyperglycemic medication (OAM).","primaryOutcome":{"measure":"Percentage of Participants With Treatment-Emergent Adverse Events (TEAEs)","timeFrame":"Baseline through 52 Weeks","effectByArm":[{"arm":"LY2189265 + SU","deltaMin":85.5,"sd":null},{"arm":"LY2189265 + BG","deltaMin":83.6,"sd":null},{"arm":"LY2189265 + a-GI","deltaMin":70.8,"sd":null},{"arm":"LY2189265 + TZD","deltaMin":80.3,"sd":null},{"arm":"LY2189265 + Glinides","deltaMin":73.2,"sd":null}],"pValues":[]},"eligibility":{"minAge":"20 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":4,"exclusionCount":5},"locations":{"siteCount":14,"countries":["Japan"]},"refs":{"pmids":[],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":9,"n":131},"commonTop":["Nasopharyngitis","Constipation","Diarrhoea","Nausea","Lipase increased"]}}